- Home
- MDGL vs ADT Comparison
MDGL vs ADT Comparison
Compare MDGL & ADT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MDGL | ADT |
|---|---|---|
| Founded | 2011 | 1874 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8B | 5.5B |
| IPO Year | 2005 | 2017 |
Fundamental Metrics
Financial Performance| Metric | MDGL | ADT |
|---|---|---|
| Price | $534.39 | $7.19 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 2 |
| Target Price | ★ $674.45 | $7.75 |
| AVG Volume (30 Days) | 205.9K | ★ 6.1M |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 3.07% |
| EPS Growth | N/A | ★ 29.63 |
| EPS | N/A | ★ N/A |
| Revenue | $180,133,000.00 | ★ $5,128,607,000.00 |
| Revenue This Year | $58.39 | $1.90 |
| Revenue Next Year | $48.55 | $2.91 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 4.70 |
| 52 Week Low | $393.61 | $6.24 |
| 52 Week High | $615.00 | $8.88 |
Technical Indicators
Market Signals| Indicator | MDGL | ADT |
|---|---|---|
| Relative Strength Index (RSI) | 50.91 | 43.28 |
| Support Level | $529.02 | $6.69 |
| Resistance Level | $546.29 | $7.16 |
| Average True Range (ATR) | 17.26 | 0.14 |
| MACD | -0.29 | -0.06 |
| Stochastic Oscillator | 59.42 | 25.40 |
Price Performance
Historical ComparisonAbout MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
About ADT ADT Inc.
ADT Inc is a provider of security, interactive, and smart home solutions serving consumer and small business customers in the United States (U.S.). The Company conducts business under the ADT brand name.